|
PDSB PDS Biotechnology Corp 1472091 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-7,349,056.00 |
| Balance Sheet |
|
Current Assets
|
$22,885,877.00 |
|
Assets
|
$24,663,026.00 |
|
Current Liabilities
|
$10,146,725.00 |
|
Liabilities
|
$20,770,383.00 |
|
Equity
|
$3,892,643.00 |
|
Shares Out
|
55815653.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,371,646.00 |
| Market Analysis |
Market Cap
|
$39,070,957.10 |
|
Price
|
$0.72 |
|
BVPS
|
0.07 |
|
PB
|
10.00 |
|
EPS
|
-0.13 |
|
FCF
|
$-4,371,646.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.74 |
|
|
2026-05-13 |
-0.13 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.21 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.19 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PDSB documents filed with the SEC.
PDSB Filings
Clear
